Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682521 | 12668252 | 1 | I | 20160811 | 20160819 | 20160819 | EXP | CA-MYLANLABS-2016M1033940 | MYLAN | 0.00 | Y | 0.00000 | 20160819 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682521 | 12668252 | 1 | PS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, QD | U | U | 71483 | 240 | MG | TABLET | QD | ||||
| 126682521 | 12668252 | 2 | SS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | U | U | 71483 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126682521 | 12668252 | 1 | Sinus tachycardia |
| 126682521 | 12668252 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126682521 | 12668252 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126682521 | 12668252 | Blood pressure increased | |
| 126682521 | 12668252 | Dyspnoea | |
| 126682521 | 12668252 | Product substitution issue | |
| 126682521 | 12668252 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |